Stay updated with breaking news from Mark Mallon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FT. MYERS, FL / ACCESSWIRE / November 30, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced
NEO earnings call for the period ending September 30, 2021.
Third-Quarter 2021 Results and Highlights:Consolidated revenue of $121 million, comprised of Clinical Services revenue of $102 million and Pharma Services revenue of $19 millionConsolidated revenue decreased
Press release content from Accesswire. The AP news staff was not involved in its creation.
NeoGenomics To Participate In The Bank of America 2021 Health Care Conference ACCESSWIRE 11 May 2021, 06:31 GMT+10 FT. MYERS, FL / ACCESSSWIRE / May 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Douglas VanOort, Executive Chairman, Mark Mallon, Chief Executive Officer, and Kathryn McKenzie, Chief Financial Officer, will be presenting at the Bank of America 2021 Health Care Conference, on Wednesday, May 12, 2021 at 4:15pm ET. The presentation will be webcast live and ...